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Background

Results

• Hemophilia represents a medical condition
suited to individualization. Adherence with
prophylactic antihemophilic factor regimens
ranges from 6%-167%.
• Clinical decision support tools (CDS) have
been shown to improve guideline compliance
and enhance patient adherence.
• The objective of this study is to evaluate the
usability, usefulness, and satisfaction of a
pharmacology-driven, patient-facing
antihemophilic factor CDS.

• Fifteen participants (9 female, 6 male, 80%
white) completed the study; 6 patients and 9
parents of patients with hemophilia.
• All were proficient with mobile technology
reporting 2-8 hr of smart device usage daily.
• All participants stated it was easy to
understand the layout and explore changes
to the dosing schedule.
• 93.3% and 86.7% reported understanding
how to change the dose amount and
simulate the new dose amount, respectively.
• All participants felt this tool will help
understand medication dosing better and
facilitate conversations with their provider.
• Content and layout changes were suggested.
• PSSUQ revealed strong ratings in all
categories.

Design/Methods
• A patient-facing CDS was created to allow
patients and families to explore factor levels
at any time and the administration of
different dosing regimens.
• Patients with hemophilia ages 10 years and
above who are currently or were previously
prescribed antihemophilic factor and parents
of patients were approached to participate.
• A cognitive walkthrough was performed to
record participant feedback and a modified
usability questionnaire (PSSUQ v.3) was
administered at the end of the session.

Discussion
• The layout and flow of our patient-facing CDS
was well received by patients and families of
patients with hemophilia.
• Participants reported a desire to use this tool
to understand medication dosing and
improve conversations with medical team.

